sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Embedded Printing of Human Respiratory Model with Air-Liquid Interface for COVID-19 Research

$176,608

Yong Huang · University Of Florida · R21 · FY2022 · HL

Therapeutic and Diagnostic Antibodies Against SARS

$176,530

Eileen C Tozer · Diversa Corporation · U01 · FY2006 · AI

Patterns of immune response in COVID-19 patients

$176,460

Robert Kreitman · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Hybrid Kinetic Monte Carlo Methods with Applications in Biofabrication and Epidemics

$176,321

Yi Sun · University Of South Carolina At Columbia · · FY2022 · MPS

SCAN-MP (Screening for Cardiac Amyloidosis with Nuclear imaging in Minority Populations) COVID-19 Suppplement

$176,033

Mathew S Maurer · Columbia University Health Sciences · R01 · FY2020 · HL

Transfer of COVID-19 Immunity Between

$176,000

Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2020 · CA

Testing a cancer patient-specific SARS-CoV-2 vaccine in chemotherapy- and radiation-treated pediatric brain tumor mouse models

$176,000

James M Olson · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA

Transfer of COVID-19 Immunity Between Allogeneic Transplant Donors and Recipients

$176,000

Stephen J Forma · Beckman Research Institute/City Of Hope · P50 · FY2020 · CA

Investigating the Contribution of Peripheral versus Central Nervous System Immune Dysfunction to Cognitive Aging

$175,934

Brianne Magouirk Bettcher · University Of Colorado Denver · R01 · FY2020 · AG

SARS-CoV-2 and respiratory virus co-infections among young children

$175,556

Annette Karena Regan · University Of San Francisco · R21 · FY2024 · AI

Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures

$175,510

Arjun Rustagi · University Of California, San Francisco · K08 · FY2024 · AI

Leveraging the sensitivity of antigen-specific T cells to interrogate disease mechanisms and identify therapeutic targets for Long COVID

$175,428

Mark M Painter · University Of Pennsylvania · K99 · FY2025 · AI

Characterization of seasonal CoV immunity and operationalization of a novel controlled human infection model for the betacoronavirus OC43

$175,300

Meagan Elise Deming · University Of Maryland Baltimore · K08 · FY2025 · AI

Maternal obesity and inflammation as drivers of maternal morbidity in COVID-19

$175,254

Andrea Goldberg Edlow · Massachusetts General Hospital · R01 · FY2020 · HD

Interaction between genetic, lifestyle and environmental factors determining circulating angiotensin-converting enzyme 2 protein expression: implications for the severity of COVID-19 infection

$175,246

Kari C. Nadeau · Stanford University · R21 · FY2022 · ES

Administrative Supplement (Equipment): Nucleic acid modulators and theranostics for ADAR

$175,170

Guizhi Zhu · Virginia Commonwealth University · R35 · FY2022 · GM

Development of technologies for evaluation of antibody response following Coronavirus Infection vs Vaccination to identify immune correlates of protection

$175,000

National Institute Of Allergy And Infectious Diseases · Y01 · FY2023 · AI

Feasibility of pharmacy-delivered patient navigation + virtual buprenorphine + HIV services

$174,890

Crystal M Fuller · New York University School Of Medicine · R34 · FY2022 · DA

Core--SARS Coronavirus Clone and Reagent

$174,680

University Of North Carolina Chapel Hill · P01 · FY2005 · AI

RAPID: Defect-Chemistry Design of Titanium Dioxide for Enhanced Virucidal Photodynamic Properties

$174,598

Elizabeth C Dickey · North Carolina State University · · FY2020 · MPS

Embedded Printing of Human Respiratory Model with Air-Liquid Interface for COVID-19 Research

Therapeutic and Diagnostic Antibodies Against SARS

Patterns of immune response in COVID-19 patients

Hybrid Kinetic Monte Carlo Methods with Applications in Biofabrication and Epidemics

SCAN-MP (Screening for Cardiac Amyloidosis with Nuclear imaging in Minority Populations) COVID-19 Suppplement

Transfer of COVID-19 Immunity Between

Testing a cancer patient-specific SARS-CoV-2 vaccine in chemotherapy- and radiation-treated pediatric brain tumor mouse models

Transfer of COVID-19 Immunity Between Allogeneic Transplant Donors and Recipients

Investigating the Contribution of Peripheral versus Central Nervous System Immune Dysfunction to Cognitive Aging

SARS-CoV-2 and respiratory virus co-infections among young children

Modeling early SARS-CoV-2 pathogenesis in human lung organoids and slice cultures

Leveraging the sensitivity of antigen-specific T cells to interrogate disease mechanisms and identify therapeutic targets for Long COVID

Characterization of seasonal CoV immunity and operationalization of a novel controlled human infection model for the betacoronavirus OC43

Maternal obesity and inflammation as drivers of maternal morbidity in COVID-19

Interaction between genetic, lifestyle and environmental factors determining circulating angiotensin-converting enzyme 2 protein expression: implications for the severity of COVID-19 infection

Administrative Supplement (Equipment): Nucleic acid modulators and theranostics for ADAR

Development of technologies for evaluation of antibody response following Coronavirus Infection vs Vaccination to identify immune correlates of protection

A Personalized, Patient-Centered Approach to Optimizing Lupus Care

A Personalized, Patient-Centered Approach to Optimizing Lupus Care

A Personalized, Patient-Centered Approach to Optimizing Lupus Care

A Personalized, Patient-Centered Approach to Optimizing Lupus Care

A Personalized, Patient-Centered Approach to Optimizing Lupus Care

Feasibility of pharmacy-delivered patient navigation + virtual buprenorphine + HIV services

Core--SARS Coronavirus Clone and Reagent

RAPID: Defect-Chemistry Design of Titanium Dioxide for Enhanced Virucidal Photodynamic Properties